News

  • Joint Statement from the Alliance for Integrity in Medicare on the GAO Report on Self-Referral Leading to Over-utilization of Pathology Services

    July 16, 2013
    The Alliance for Integrity in Medicare (AIM)—a broad coalition of physical therapy, laboratory, radiation oncology, and medical imaging groups committed to ending the practice of inappropriate physician self-referral—applauds the findings of the Government Accountability Office (GAO) released July 15, 2013, “Action Needed to Address Higher Use of Anatomic Pathology Services by Providers Who Self-Refer.” AIM believes these findings add significantly to the existing mountainContinue Reading »...
  • ACLA Applauds GAO Report Finding Financial Incentives Drive Anatomical Pathology Self-Referral Practices in Medicare

    July 16, 2013
    Washington, DC – The American Clinical Laboratory Association (ACLA) applauds the release of the new Government Accountability Office (GAO) Report to Congress, examining self-referral practices within Medicare for anatomic pathology services. Entitled “Action Needed to Address Higher Use of Anatomic Pathology Services by Providers Who Self-Refer (GAO-12-455),” this study investigated the impact of self-referral on anatomic pathology services, which play a critical role inContinue Reading »...
  • Clinical Labs Voice ‘Deep’ Concern with Proposed Medicare Fee Schedule

    July 12, 2013
    The American Clinical Laboratory Association said this week it is “deeply concerned” about two types of cuts in a proposed Medicare payment regulation to be published next week in the Federal Register. “First, absent any discussion with clinical laboratories, patients, and other stakeholders, CMS proposes to identify codes and propose revised payments in the Clinical Laboratory Fee Schedule due to ‘technological changes,’” the lobby said in aContinue Reading »...
  • Letter from CLC to HHS OIG Meeting Request

    July 11, 2013
      Daniel R. Levinson Inspector General Department of Health and Human Services Office of Inspector General 330 Independence Avenue, SW Washington, DC 20201 Dear Mr. Levinson: On behalf of the undersigned organizations—representing America’s community, regional, hospital-based, and national clinical laboratories; the laboratory professionals who provide care for the Medicare patients we serve; and diagnostic manufacturers—we write to request a meeting with your office toContinue Reading »...
  • Statement on CMS Proposed Physician Fee Schedule Rule

    July 09, 2013
    WASHINGTON, DC – The American Clinical Laboratory Association (ACLA) issued the following statement on the proposed rule published today in the Federal Register by the Centers for Medicare and Medicaid Services (CMS), “Medicare Program: Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other Revisions for Part B for CY 2014” (the “Proposed Rule”): ACLA is deeply concerned withContinue Reading »...
  • Statement on CMS Proposed Physician Fee Schedule Rule

    July 09, 2013
    WASHINGTON, DC – The American Clinical Laboratory Association (ACLA) issued the following statement on the proposed rule published today in the Federal Register by the Centers for Medicare and Medicaid Services (CMS), “Medicare Program: Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other Revisions for Part B for CY 2014” (the “Proposed Rule”): ACLA is deeply concerned withContinue Reading »...
  • ACLA Submits Comments on Gapfill Pricing for Molecular Pathology Services

    July 02, 2013
    (WASHINGTON, D.C.) The American Clinical Laboratory Association (ACLA) submitted comments today to the Centers for Medicare & Medicaid Services’ (CMS) regarding the agency’s 2013 gapfill pricing under the Clinical Laboratory Fee Schedule (CLFS) for molecular pathology services. For 2013, CMS decided to use the gapfilling methodology to establish payment rates for more than 100 new Tier I and Tier II molecular pathology test codesContinue Reading »...
  • Comments Regarding CMS Proposed Requirements for the Medicare Incentive Reward Program and Provider Enrollment

    June 27, 2013
      Marilyn Tavenner, Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attn: CMS-1454-P P.O. Box 8013 Baltimore, Maryland 21244-8013 Re: Proposed Rule: Requirements for the Medicare Incentive Reward Program and Provider Enrollment, CMS-6045-P Dear Ms. Tavenner: The American Clinical Laboratory Association (“ACLA”) is pleased to have the opportunity to submit comments on the Centers for Medicare and Medicaid Services’Continue Reading »...
  • Clinical Lab Industry Files Petition Challenging FDA’s Authority to Regulate LDTs

    June 12, 2013
    The American Clinical Laboratory Association (ACLA) June 4 filed a citizenpetition challenging the Food and Drug Administration’s authority to regulate laboratory developed tests (LDTs) as medical devices. ACLA is attempting to head off any effort by FDA to regulate such tests, which currently are regulated under the Clinical Laboratory Improvement Amendments (CLIA) by a different agency, the Centers for Medicare & Medicaid Services. The petitionContinue Reading »...
  • Statement Regarding OIG Report on Medicare Spending on Clinical Lab Services

    June 12, 2013
    Washington, D.C. (June 12, 2013) – The Department of Health and Human Services (HHS) Office of Inspector General (OIG) yesterday released a report, “Comparing Lab Test Payment Rates: Medicare Could Achieve Substantial Savings.” The report examined 20 of the 1100 laboratory test codes (HCPCS) and concluded that Medicare paid “more than other insurers” for these codes. The American Clinical Laboratory Association (ACLA) saw theContinue Reading »...